A surgeon by background, Chris has extensive knowledge and experience in healthcare. He is the head of our Medical Products Practice in EMEA and a core leader in our global Pharmaceuticals Practice.
Since joining in 2004, Chris has partnered with executives and leaders across the healthcare sector—working with health systems, payors, providers, pharmaceutical companies, medical device manufacturers and private equity. His work focuses on strategic performance improvement, including defining and implementing novel commercial approaches, refining the operating model, controlling costs, improving product development and finding new sources of growth.
An occasional advisor to national governments, Chris also helps guide large-scale public investments in the life sciences. He has worked with the President of Israel to plan a world-leading neurotechnology cluster, and he helped the UK Prime Minister develop a national life sciences strategy, focused on attracting investment and boosting employment in the sector and beyond.
Examples of his work include:
- developing a turnaround and growth plan for one of the world's largest medical products companies
- redesigning the portfolio of one of the leading diagnostics companies and identifying new avenues for growth
- supporting the integration of a multibillion dollar medical products acquisition—ensuring value capture and planning for Day 1 readiness
- redesigning the go-to-market commercial model for a leading medical products company, including establishing new customer segmentation and business models
Strongly interested in the evolution of implantable medical devices, he has evaluated trends and sought to identify next generation products and emerging business models. Chris has contributed to white papers in the field and is a frequent speaker at professional association meetings and industry conferences.
Before joining McKinsey, Chris worked as a surgeon in the UK National Health Service, conducted research in neuroscience, and taught at Imperial College, London. Chris also sits on the board of the World Dementia Council.
“Improving healthcare while curbing cost: Med-tech companies offer a solution,” McKinsey & Company, October 2015
“Capturing the new 'value' segment in medical devices,” McKinsey & Company, January 2015
Imperial College London
MBBS (with distinction), surgery and medicine
University of Oxford
MA (with honors), physiological sciences